Improvement of Atazanavir-Induced Hyperbilirubinaemia Following TDM-guided Atazanavir Dose Reduction

Journal of the International AIDS Society - Switzerland
doi 10.1186/1758-2652-11-s1-p234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients

AAPS Journal
Pharmaceutical Science
2012English

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Ureteral Obstruction Due to Radiolucent Atazanavir Ureteral Stones

Journal of Endourology Case Reports
Urology
2017English

Liver Profile of Atazanavir/Ritonavir in Pregnant Albino Rats

Biology, Medicine, & Natural Product Chemistry
2019English

Atazanavir Exposure Is Effective During Pregnancy, Regardless of Tenofovir Use

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Estratégia De Proteção De Patentes Farmacêuticas: O Caso Do Atazanavir

Revista Eletrônica de Comunicação, Informação e Inovação em Saúde
2016English

Protease Inhibitor Atazanavir Induces Leukocyte-Endothelial Cell Interactions in the Microvasculature

Journal of the International AIDS Society
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2008English

Formulation Development and Evaluation of Gastro-Retentive Dosage Form of Atazanavir Sulphate

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2018English

Safety of Darunavir and Atazanavir in HIV-infected Children in Europe and Thailand

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy